Previous Close | 273.82 |
Open | 273.82 |
Bid | 403.35 |
Ask | 411.65 |
Strike | 560.00 |
Expire Date | 2025-03-21 |
Day's Range | 273.82 - 273.82 |
Contract Range | N/A |
Volume | |
Open Interest | 2 |
Eli Lilly halved the price of a new version of its weight-loss drug, Zepbound. Is Eli Lilly stock a buy right now?
NVO stock gains 4.2% after it presents efficacy data superior to Wegovy for its new oral pill, amycretin, in an early-stage study.
With this latest approval, JNJ's Tremfya is approved for a total of three immunology indications.